The purpose of the study is to evaluate a sustainable and broadly accessible treatment delivery model (Motiv8) for smoking cessation based on abstinence-reinforcement.
Smokers are randomly assigned to one of two groups: an Abstinence Contingent (AC) group and a Submission Contingent (SC) group. The AC group receives vouchers for abstaining from smoking (measured by a carbon monoxide monitor and confirmed through video-submission), and the SC group receives vouchers for submitting videos of their carbon monoxide breath tests. Both groups take videos of their CO-monitoring on a secure website designed for the study, as well as receive standard care counseling and education related to smoking cessation. The main intervention lasts four weeks, and a three-week maintenance phase will follow. Assessments will be conducted at intake, week four (end of the main treatment phase), and at three and six months after the intervention period is completed
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
96
Participants in this intervention group will receive vouchers contingent upon a CO sample of 4ppm or less.
This intervention group will receive vouchers contingent on their submission of videos of their CO breath tests.
National Development and Research Institutes
New York, New York, United States
CO sample of ≤ 4ppm
Time frame: 4 weeks, 7 weeks during intervention; 3 months and 6 months after intervention
Participant reporting not smoking, not even a puff in the last 7 days.
Time frame: 4 weeks, 7 weeks during intervention; 3 months and 6 months after intervention
Twice-daily breath CO samples obtained during treatment period.
Time frame: First 4 weeks of treatment
The longest duration of sustained abstinence based on the twice-daily breath samples during the treatment period.
Time frame: First 4 weeks of treatment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.